Aldeyra Therapeutics Inc (NASDAQ: ALDX) on Friday, plunged -9.85% from the previous trading day, before settling in for the closing price of $5.18. Within the past 52 weeks, ALDX’s price has moved between $1.14 and $7.20.
A company in the Healthcare sector has jumped its sales by 15.99% annually for the last half of the decade. The company achieved an average annual earnings per share of 34.31%. With a float of $58.21 million, this company’s outstanding shares have now reached $60.16 million.
Aldeyra Therapeutics Inc (ALDX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Aldeyra Therapeutics Inc is 3.24%, while institutional ownership is 65.68%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.27 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.22) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.31% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Aldeyra Therapeutics Inc (ALDX) is currently performing well based on its current performance indicators. A quick ratio of 2.68 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
As of the previous 9 days, the stock’s Stochastic %D was 22.70%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 32.66%, which indicates a significant decrease from 40.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was higher than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.03, while its 200-day Moving Average is $4.43. However, in the short run, Aldeyra Therapeutics Inc’s stock first resistance to watch stands at $5.03. Second resistance stands at $5.40. The third major resistance level sits at $5.59. If the price goes on to break the first support level at $4.48, it is likely to go to the next support level at $4.29. Assuming the price breaks the second support level, the third support level stands at $3.92.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
Market capitalization of the company is 280.96 million based on 60,163K outstanding shares. Right now, sales total 0 K and income totals -55,850 K. The company made 0 K in profit during its latest quarter, and -7,690 K in sales during its previous quarter.
